Research is limited by our own thinking – until now.James Field, CEO and co-founder of <a href="https://labgeniustx.com/" rel="noopener noreferrer" target="_blank">LabGenius</a>, reflects on becoming a first-time CEO, the challenges that came with founding a company and the contrast between traditional research and what's possible using modern tools and technology in this episode of <a href="https://www.lifescienceorg.com/call-to-lead" rel="noopener noreferrer" target="_blank">A Call to Lead</a>.

Research is limited by our own thinking – until now. James Field, CEO and co-founder of LabGenius, reflects on becoming a first-time CEO, the challenges that came with founding a company and the contrast between traditional research and what's possible using modern tools and technology in this episode of A Call to Lead.

Research is limited by our own thinking – until now.James Field, CEO and co-founder of <a href="https://labgeniustx.com/" rel="noopener noreferrer">LabGenius</a>, reflects on becoming a first-time CEO, the challenges that came with founding a company and the contrast&nbsp;between traditional research and what's possible using modern&nbsp;tools and&nbsp;technology in this episode of <a href="https://www.lifescienceorg.com/call-to-lead" rel="noopener noreferrer">A Call to Lead</a>.

James Field, LabGenius Therapeutics

A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare. 

Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly. 

New episodes are released every Thursday.

Business

Entrepreneurship

Science

Technology

Life Sciences

A Call To Lead is a series shining a light on the leadership, vision, and impact of European life science CEOs who are proving that world-class ventures don’t need to be built in Boston to shape the future of healthcare. Each episode features a one-on-one conversation with a European life science CEO and member of the LifeScience ORG community. Our conversations are not about companies or pipelines; instead, guests reflect on their personal journeys, the pivotal choices that shaped their careers, and the future they are helping to build. These kinds of insights are rarely shared publicly. New episodes are released every Thursday.

Share James Field, LabGenius Therapeutics

Sign up to save your podcasts

James Field, LabGenius Therapeutics

James Field, LabGenius Therapeutics